Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -991 | -714 | N/A | N/A | N/A |
| Depreciation Amortization | 5 | N/A | N/A | N/A | N/A |
| Accounts receivable | -735 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 969 | -3 | N/A | N/A | N/A |
| Other Working Capital | 422 | 78 | N/A | N/A | N/A |
| Other Operating Activity | -146 | 80 | 0 | 0 | 0 |
| Operating Cash Flow | $-477 | $-559 | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 530 | N/A | N/A | N/A | N/A |
| Common Stock Issued | N/A | 3 | N/A | N/A | N/A |
| Other Financing Activity | -87 | 244 | 0 | 0 | 0 |
| Financing Cash Flow | $443 | $246 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 35 | 348 | N/A | N/A | N/A |
| End Cash Position | 2 | 35 | N/A | N/A | N/A |
| Net Cash Flow | $-34 | $-312 | $N/A | $N/A | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | -477 | -559 | N/A | N/A | N/A |
| Free Cash Flow | -477 | -559 | 0 | 0 | 0 |